Iranian Journal of Medical Sciences

Document Type : Brief Report(s)

Authors

1 State Healthcare Institution Regional Clinical Oncology Center, Ulyanovsk State University, Ulyanovsk, Russia

2 Department of Surgery, Faculty of Medicine named after T.Z. Biktimirova, Institute of Medicine, Ecology and Physical Culture, Ulyanovsk State University, Ulyanovsk, Russia

3 National Medical Research Center of Phthisiopulmonology, P.A. Hertzen Moscow Oncology Research Institute, Branch of the National Medical Research Radiological Center, Ministry of Health of Russia, Moscow, Russia

4 P.A. Hertzen Moscow Oncology Research Institute, Branch of the National Medical Research Radiological Center, Ministry of Health of Russia, Moscow, Russia

5 State Healthcare Institution, Regional Clinical Oncology Center, Ulyanovsk, Ulyanovsk, Russia

6 Department of Hospital Surgery, Ulyanovsk State University, Ulyanovsk, Russia

7 Anesthesiology, Resuscitation, Urology, Traumatology and Orthopedics, Ulyanovsk State University, Ulyanovsk, Russia

Abstract

Surgery is pivotal in treating esophageal cancer; hybrid esophagectomy, which combines minimally invasive and open techniques, shows promising outcomes. This historical cohort study compared the surgical outcomes of standard open esophagectomy with hybrid esophagectomy. Overall, 58 patients who underwent either hybrid or open esophagectomy at the Ulyanovsk Regional Clinical Oncology Clinic, Russia, from January 2015 to December 2023 were included. Data on demographics, surgical details, and postoperative outcomes were analyzed. The primary measures were overall complications and anastomotic leakage rates. Statistical analysis was performed using Pearson’s Chi square test and t test via StatTech software (version 2.8.8). The number of removed lymph nodes was higher in the hybrid group (24±9) than in the open group (15±7) (P<0.001). In addition, the hybrid esophagectomy group showed significant reductions in operational time and blood loss (P<0.001 and P=0.014, respectively). The need for blood transfusion was higher in the open esophagectomy group (P=0.043). The postoperative length of stay in the hospital did not differ significantly between the two groups (open=20±8 days, hybrid=17±7 days, P=0.178). Cardiac complications were more frequent after an open esophagectomy (P=0.044). Hybrid esophagectomy reduced postoperative cardiac complications and other adverse events while maintaining satisfactory oncological outcomes. It had advantages over standard open esophagectomy in terms of lymphadenectomy, operative time, blood loss, and transfusion requirements, suggesting its efficacy for esophageal cancer patients.

Keywords

  1. Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D’Journo XB, et al. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262:286-94. doi: 10.1097/SLA.0000000000001098. PubMed PMID: 25607756.
  2. Sobolev DD, Mamontov AS, Khomyakov VM, Vashakmadze LA, Ryabov AB, Cheremisov VV, et al. Results of surgical and combined treatment in patients with thoracic esophageal carcinoma: Ten-year experience of the PA Herzen Moscow Oncology Research Institute. PA Herzen Journal of Oncology. 2018:4-14. doi: 10.17116/onkolog2018744.
  3. Clinical guidelines [Internet]. Cancer of the esophagus and cardia: Association of Oncologists of Russia. c2021. Available from: https://oncology-association.ru/wp-content/uploads/2021/04/kr_rak-pishhevoda-i-kardii_aor_30.03.2021.pdf
  4. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. New Jersey: Wiley-Blackwell; 2016.
  5. Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surg. 2006;95:260-9. doi: 10.1177/145749690609500409. PubMed PMID: 17249275.
  6. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55. PubMed PMID: 7165009.
  7. Seely AJ, Ivanovic J, Threader J, Al-Hussaini A, Al-Shehab D, Ramsay T, et al. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg. 2010;90:936-42. doi: 10.1016/j.athoracsur.2010.05.014. PubMed PMID: 20732521.
  8. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63. doi: 10.3322/caac.21834. PubMed PMID: 38572751.
  9. Shakhzadova A, Starinsky V. Lisichnikova IV. Cancer care to the population of Russia in 2022. Siberian Journal of Oncology. 2023;22:5-13. doi: 10.21294/1814-4861-2023-22-5-5-13.
  10. Mariette C, Markar S, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, et al. Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial. Ann Surg. 2020;271:1023-9. doi: 10.1097/SLA.0000000000003559. PubMed PMID: 31404005.
  11. Dantoc M, Cox MR, Eslick GD. Evidence to support the use of minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Arch Surg. 2012;147:768-76. doi: 10.1001/archsurg.2012.1326. PubMed PMID: 22911078.